HighMark Wealth Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23K Hold
50
﹤0.01% 456
2026
Q1
$2.58K Buy
50
+20
+67% +$1.4K ﹤0.01% 437
2025
Q4
$2.77K Buy
30
+10
+50% +$957 ﹤0.01% 462
2025
Q3
$1.48K Buy
20
+11
+122% +$1.11K ﹤0.01% 506
2025
Q2
$1.17K Sell
9
-9
-50% -$1.3K ﹤0.01% 519
2025
Q1
$2.87K Hold
18
﹤0.01% 426
2024
Q4
$3.34K Hold
18
﹤0.01% 411
2024
Q3
$3.8K Sell
18
-27
-60% -$4.69K ﹤0.01% 423
2024
Q2
$6.02K Buy
+45
New +$8.52K ﹤0.01% 360
2024
Q1
Sell
-25
Closed -$5.09K 586
2023
Q4
$5.09K Buy
+25
New +$4.05K ﹤0.01% 368

Other funds holding INSP

HighMark Wealth Management's INSP Position: Q2 2026 in Review

HighMark Wealth Management held its Inspire Medical Systems (INSP) position steady in Q2 2026 at 50 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

HighMark Wealth Management first reported a position in INSP in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.02K in Q2 2024. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • HighMark Wealth Management held 50 shares of Inspire Medical Systems worth $2.23K as of Q2 2026.
  • HighMark Wealth Management left its Inspire Medical Systems share count unchanged in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #456 holding.
  • HighMark Wealth Management first reported a position in Inspire Medical Systems in Q4 2023 and has held it in 10 quarters since.
  • HighMark Wealth Management's Inspire Medical Systems position peaked at $6.02K in Q2 2024.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.